{"ref-id":"F1718","title":"Peg-interferon FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/718/original/peg.pdf?1538425761","parent_key":"BE0002433"}
{"ref-id":"F1719","title":"Peg-interferon alfa-2b FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/719/original/Peg_interferon_Alpha_2b.pdf?1538425985","parent_key":"BE0002433"}
{"ref-id":"F1814","title":"Sylatron FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/814/original/103949s5153lbl.pdf?1539291183","parent_key":"BE0002793"}
{"ref-id":"F1722","title":"PEG-Intron package insert","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/722/original/PEG-Intron_%28Peginterferon_alfa-2b%29_Package_Insert.pdf?1538428037","parent_key":"BE0002433"}
{"ref-id":"F1694","title":"Fluvoxamine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/694/original/Fluvoxamine_FDA_label.pdf?1538148014","parent_key":"BE0002433"}
{"ref-id":"F3283","title":"QSYMIA (phentermine/topiramate) FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/283/original/fda.pdf?1549057509","parent_key":"BE0002638"}
{"ref-id":"F1635","title":"CYp1A3 CTEP document, cancer.gov","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/635/original/cyp1a2.doc?1537809665","parent_key":"BE0002433"}
{"ref-id":"F1636","title":"Companion Dx reference lab document: EXPANDED TEST OFFERING IN PHARMACOGENOMICS: CYP1A2","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/636/original/PGX_CYP1A2_V11.15.pdf?1537809788","parent_key":"BE0002433"}
{"ref-id":"F1870","title":"Sildenafil FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/870/original/Sildenafil_FDA_label.pdf?1539705689","parent_key":"BE0002793"}
{"ref-id":"F1612","title":"List of drugs that may have potential CYP2E1 interactions","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/612/original/cyp2e1.doc?1537551487","parent_key":"BE0003533"}
{"ref-id":"F3202","title":"Protonix delayed release and oral suspension FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/202/original/Protonix_Delayed_relase_and_ora_susp.pdf?1548780962","parent_key":"BE0002638"}
{"ref-id":"F1709","title":"Citalopram FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/709/original/fda_lalbel_citalopram.pdf?1538411342","parent_key":"BE0002433"}
{"ref-id":"F3289","title":"MedSafe NZ Data Sheet, Citalopram","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/289/original/ArrowCitalopramtab.pdf?1549058792","parent_key":"BE0002433"}
{"ref-id":"F4661","title":"FDA Label - Lovastatin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/661/original/FDA_Label_-_Lovastatin.pdf?1564095428","parent_key":"BE0002638"}
{"ref-id":"F4664","title":"Health Canada Monograph - Lovastatin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/664/original/Health_Canada_Monograph_-_Lovastatin.PDF?1564095447","parent_key":"BE0002638"}
{"ref-id":"F1805","title":"Get to Know an Enzyme: CYP2C9","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/805/original/hh-article03-08.pdf?1539206607","parent_key":"BE0002793"}
{"ref-id":"F3058","title":"CYP3A4 document, CTEP","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/058/original/cyp3a4.doc?1548197366","parent_key":"BE0002638"}
{"ref-id":"F3067","title":"MEDICATIONS METABOLIZED BY CYTOCHROME P450 3A4","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/067/original/Methadone-Medications-Cytochrome-P450-3A4.pdf?1548263322","parent_key":"BE0002638"}
{"ref-id":"F3109","title":"Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/109/original/f8f0fa4c75a43c495dc78c565e099be799dd.pdf?1548350296","parent_key":"BE0002638"}
{"ref-id":"F3112","title":"Genetic Polymorphism of CYP2D6","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/112/original/Genetic_polymorphism_of_CYP2D6.pdf?1548350917","parent_key":"BE0002363"}
{"ref-id":"F1907","title":"A Review on Drug Interactions in Oral Hypoglycemic Drugs by Mechanism of Cytochrome P450 Enzyme Inhibition","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/907/original/116434-271285-1-PB.pdf?1539880022","parent_key":"BE0002793"}
{"ref-id":"F1598","title":"Ropinrole FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/598/original/Ropinrole_FDA_label.pdf?1537463837","parent_key":"BE0002433"}
{"ref-id":"F1591","title":"Theophylline FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/591/original/CYP1A2_Theophylline.pdf?1537457669","parent_key":"BE0002433"}
{"ref-id":"F1599","title":"CTEP CYP1A2 DOCUMENT","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/599/original/cyp1a2.doc?1537465701","parent_key":"BE0002433"}
{"ref-id":"F1600","title":"Ropivacaine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/600/original/Ropivacaine_FDA_label.pdf?1537466348","parent_key":"BE0002433"}
{"ref-id":"F4139","title":"Acetaminophen FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/139/original/Acetaminophen_Injection_FDA_label.pdf?1553717049","parent_key":"BE0003533"}
{"ref-id":"F3664","title":"Codeine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/664/original/Codeine_FDA_label.pdf?1551127714","parent_key":"BE0002363"}
{"ref-id":"F3673","title":"Codeine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/673/original/Codeine_FDA_label.pdf?1551131264","parent_key":"BE0002638"}
{"ref-id":"F3667","title":"Codeine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/667/original/Codeine_FDA_label.pdf?1551129872","parent_key":"BE0003679"}
{"ref-id":"F3670","title":"Codeine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/670/original/Codeine_FDA_label.pdf?1551130183","parent_key":"BE0003681"}
{"ref-id":"F2206","title":"Dihydroergotamine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/206/original/Dihydroergotamine_FDA.pdf?1544554777","parent_key":"BE0002638"}
{"ref-id":"F3556","title":"Amitriptyline FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/556/original/Amitriptyline_FDA_label.pdf?1550616396","parent_key":"BE0002363"}
{"ref-id":"F1466","title":"Wang et al. (2004). Clin Pharmacol Ther. 75:191-197","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/466/original/CYP2C19__Wang_et_al..pdf?1536681026","parent_key":"BE0003536"}
{"ref-id":"F4685","title":"FDA Label - Methadone","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/685/original/FDA_Label_-_methadone.pdf?1566927671","parent_key":"BE0002638"}
{"ref-id":"F4685","title":"FDA Label - Methadone","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/685/original/FDA_Label_-_methadone.pdf?1566927671","parent_key":"BE0003536"}
{"ref-id":"F4685","title":"FDA Label - Methadone","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/685/original/FDA_Label_-_methadone.pdf?1566927671","parent_key":"BE0002887"}
{"ref-id":"F4685","title":"FDA Label - Methadone","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/685/original/FDA_Label_-_methadone.pdf?1566927671","parent_key":"BE0002433"}
{"ref-id":"F4685","title":"FDA Label - Methadone","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/685/original/FDA_Label_-_methadone.pdf?1566927671","parent_key":"BE0002793"}
{"ref-id":"F1601","title":"Olanzapine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/601/original/Olanzapine_FDA_label.pdf?1537471035","parent_key":"BE0002433"}
{"ref-id":"F1486","title":"Olanzapine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/486/original/Olanzapine_FDA_label.pdf?1536947153","parent_key":"BE0003536"}
{"ref-id":"F1601","title":"Olanzapine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/601/original/Olanzapine_FDA_label.pdf?1537471035","parent_key":"BE0002793"}
{"ref-id":"F3715","title":"Prilosec FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/715/original/Prilosec_FDA.pdf?1551291606","parent_key":"BE0002638"}
{"ref-id":"F3706","title":"Prilosec FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/706/original/Prilosec_FDA.pdf?1551224562","parent_key":"BE0003536"}
{"ref-id":"F2270","title":"WHO: PHARMACEUTICALS: RESTRICTIONS IN USE AND AVAILABILITY","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/270/original/who_emp_qsm2008.3.pdf?1544726582","parent_key":"BE0002638"}
{"ref-id":"F1514","title":"Cancer. gov CTEP protocol developments","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/514/original/cyp2c19.doc?1537221138","parent_key":"BE0003536"}
{"ref-id":"F1906","title":"A Review on Drug Interactions in Oral Hypoglycemic Drugs by Mechanism of Cytochrome P450 Enzyme Inhibition","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/906/original/116434-271285-1-PB.pdf?1539879975","parent_key":"BE0002793"}
{"ref-id":"F4594","title":"Remeron tablets FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/594/original/Remeron_tablets__FDA_label.pdf?1556741198","parent_key":"BE0002638"}
{"ref-id":"F4594","title":"Remeron tablets FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/594/original/Remeron_tablets__FDA_label.pdf?1556741198","parent_key":"BE0002363"}
{"ref-id":"F1602","title":"Mirtazapine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/602/original/FDA_label__Mirtazapine.pdf?1537473633","parent_key":"BE0002433"}
{"ref-id":"F1627","title":"Palonosetron FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/627/original/Palonosetron_FDA_label.pdf?1537568523","parent_key":"BE0002433"}
{"ref-id":"F3766","title":"Amlodipine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/766/original/Amlodipine_FDA_label.pdf?1551718622","parent_key":"BE0002638"}
{"ref-id":"F4081","title":"Carisoprodol FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/081/original/Carisoprodol_FDA_label.pdf?1553272900","parent_key":"BE0003536"}
{"ref-id":"F3931","title":"Prometrium FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/931/original/Prometrium_FDA_label.pdf?1552429629","parent_key":"BE0002638"}
{"ref-id":"F1871","title":"Sorafenib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/871/original/sorafenib_fda.pdf?1539705871","parent_key":"BE0002793"}
{"ref-id":"F1889","title":"Rosiglitazone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/889/original/Rosiglitazone_fda.pdf?1539711844","parent_key":"BE0002793"}
{"ref-id":"F1525","title":"Phenobarbital product monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/525/original/Phenobarbital_Product_Monograph.pdf?1537290567","parent_key":"BE0003536"}
{"ref-id":"F3862","title":"Ambien FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/862/original/Ambien_FDA_label.pdf?1552002346","parent_key":"BE0002638"}
{"ref-id":"F4045","title":"BMJ Article: Allopurinol metabolism in a patient with xanthine oxidase deficiency","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/045/original/Allopurinolmetabolismina_patientwithxanthine_oxidasedeficiency.pdf?1553117756","parent_key":"BE0003539"}
{"ref-id":"F3982","title":"FDA label, Allopurinol","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/982/original/Allopurinol_FDA_label.pdf?1552949475","parent_key":"BE0002204"}
{"ref-id":"F2219","title":"Trimethoprim FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/219/original/Trimethoprim_FDA_label.pdf?1544568404","parent_key":"BE0002887"}
{"ref-id":"F762","title":"Celestone monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/762/original/1.pdf?1532386869","parent_key":"BE0002638"}
{"ref-id":"F1904","title":"Teniposide monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/904/original/Teniposide_monograph_1July2014.pdf?1539879288","parent_key":"BE0002793"}
{"ref-id":"F1632","title":"FDA label Quinine","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/632/original/FDA_label_Quinine.pdf?1537805198","parent_key":"BE0002433"}
{"ref-id":"F1899","title":"Quinine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/899/original/FDA_label_Quinine.pdf?1539806359","parent_key":"BE0002793"}
{"ref-id":"F1928","title":"Montelukast FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/928/original/FDA_label_montelukast.pdf?1539963705","parent_key":"BE0002793"}
{"ref-id":"F1603","title":"Duloxetine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/603/original/Duloxetine_FDA_label.pdf?1537474340","parent_key":"BE0002433"}
{"ref-id":"F1626","title":"Chlorpromazine Prescribing Info","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/626/original/Chlorpromazine-Thorazine-FDA-Label.pdf?1537563847","parent_key":"BE0002433"}
{"ref-id":"F1638","title":"Nabilone FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/638/original/018677s011lbl.pdf?1537810630","parent_key":"BE0003533"}
{"ref-id":"F1922","title":"Cimetidine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/922/original/Cimetidine_FDA_label.pdf?1539894834","parent_key":"BE0002793"}
{"ref-id":"F1816","title":"Ritonavir FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/816/original/RItonavir_FDA.pdf?1539294174","parent_key":"BE0002793"}
{"ref-id":"F1699","title":"FDA, ritonavir","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/699/original/Ritonavir_FDA.pdf?1538153612","parent_key":"BE0002433"}
{"ref-id":"F1644","title":"Albendazole FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/644/original/FDA_label_Albenza.pdf?1537820247","parent_key":"BE0002433"}
{"ref-id":"F1653","title":"Erlotinib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/653/original/Erlotinib_FDA.pdf?1537898295","parent_key":"BE0002433"}
{"ref-id":"F1829","title":"Cyclophosphamide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/829/original/Cyclophosphamide_FDA.pdf?1539382562","parent_key":"BE0002793"}
{"ref-id":"F1875","title":"Zafirlukast FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/875/original/zafi.pdf?1539707489","parent_key":"BE0002793"}
{"ref-id":"F1815","title":"Bosentan FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/815/original/BOSENTAN_FDA_LABEL.pdf?1539292391","parent_key":"BE0002793"}
{"ref-id":"F1584","title":"CP450 drug interactions","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/584/original/cyp450_drug_interactions.pdf?1537394923","parent_key":"BE0002433"}
{"ref-id":"F1810","title":"Tegretol FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/810/original/Tegretol_FDA.pdf?1539209452","parent_key":"BE0002793"}
{"ref-id":"F1614","title":"Propranolol FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/614/original/propranolol_fda_label.pdf?1537552115","parent_key":"BE0002433"}
{"ref-id":"F1924","title":"FDA label, Dilantin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/924/original/Dilantin_Infatabs_OS_PM_E_19Dec2017.pdf?1539902326","parent_key":"BE0002793"}
{"ref-id":"F1876","title":"Valdexocib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/876/original/FDA_label_Valdecoxib.pdf?1539707791","parent_key":"BE0002793"}
{"ref-id":"F1929","title":"EMA public statement: Valdecoxib","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/929/original/emea-public-statement-valdecoxib-parecoxib-sodium-cardiovascular-risks-coronary-artery-bypass-graft_en.pdf?1539965585","parent_key":"BE0002793"}
{"ref-id":"F2210","title":"Voriconazole FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/210/original/Voriconazole_FDA_label.pdf?1544560320","parent_key":"BE0002638"}
{"ref-id":"F1869","title":"Voriconazole FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/869/original/Voriconazole_FDA_label.pdf?1539705288","parent_key":"BE0002793"}
{"ref-id":"F1698","title":"Pharmacogenomic Association Table","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/698/original/Pharmacogenomic_Associations_Tables.pdf?1538151452","parent_key":"BE0002433"}
{"ref-id":"F1452","title":"Pharmacists' Letter/Prescribers' Letter: Cytochrome P450 Drug Interactions","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/452/original/cyp450_drug_interactions.pdf?1536601307","parent_key":"BE0002887"}
{"ref-id":"F1631","title":"Imatinib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/631/original/Imatinib_FDA_label.pdf?1537804473","parent_key":"BE0002433"}
{"ref-id":"F1898","title":"Imatinib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/898/original/Imatinib_FDA_label.pdf?1539805701","parent_key":"BE0002793"}
{"ref-id":"F1908","title":"Efavirenz FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/908/original/Efavirenz_fda.pdf?1539881058","parent_key":"BE0002793"}
{"ref-id":"F1354","title":"Efavirenz FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/354/original/Efavirenz_FDA_label.pdf?1535736090","parent_key":"BE0002638"}
{"ref-id":"F1711","title":"Efavirenz FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/711/original/FDA_label_Efavirenz.pdf?1538412865","parent_key":"BE0002433"}
{"ref-id":"F1640","title":"CYP1A2 cancer.gov document","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/640/original/cyp1a2.doc?1537816612","parent_key":"BE0002433"}
{"ref-id":"F1518","title":"Cytochrome P450 drug interactions","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/518/original/cyp450_drug_interactions.pdf?1537284698","parent_key":"BE0003536"}
{"ref-id":"F1519","title":"Mayo medical laboratory document","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/519/original/Mayo_medical_laboratory_document.pdf?1537284852","parent_key":"BE0003536"}
{"ref-id":"F4655","title":"FDA Label - Simvastatin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/655/original/FDA_Label_-_simvastatin.pdf?1564075804","parent_key":"BE0002638"}
{"ref-id":"F4658","title":"Health Canada Monograph - Simvastatin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/658/original/Health_Canada_Monograph_-_Simvastatin.PDF?1564075821","parent_key":"BE0002638"}
{"ref-id":"F1806","title":"Aprepitant FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/806/original/Aprepitant_FDA_label.pdf?1539207345","parent_key":"BE0002793"}
{"ref-id":"F1931","title":"Tamoxifen FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/931/original/Tamoxifen_FDA.pdf?1539966188","parent_key":"BE0002793"}
{"ref-id":"F1878","title":"FDA label Losartan","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/878/original/FDA_label_losa.pdf?1539708399","parent_key":"BE0002793"}
{"ref-id":"F1879","title":"Warfarin FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/879/original/Warf_FDA.pdf?1539708508","parent_key":"BE0002793"}
{"ref-id":"F1592","title":"FDA label warfarin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/592/original/FDA_label__Warfarin.pdf?1537459656","parent_key":"BE0002433"}
{"ref-id":"F787","title":"Vienna presentation 2012","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/787/original/1.pdf?1532464324","parent_key":"BE0002638"}
{"ref-id":"F1616","title":"Tizanidine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/616/original/tizanidine_fda_label.pdf?1537557887","parent_key":"BE0002433"}
{"ref-id":"F2273","title":"Eplenerone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/273/original/Eplenerone_FDA_label.pdf?1544731885","parent_key":"BE0002638"}
{"ref-id":"F1863","title":"Delavirdine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/863/original/Delarvidine_FDA_label.pdf?1539641661","parent_key":"BE0002793"}
{"ref-id":"F2009","title":"Sufentanil EMA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/009/original/zalviso-epar-product-information_en.pdf?1541442012","parent_key":"BE0002638"}
{"ref-id":"F1932","title":"Flurbiprofen FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/932/original/Flurbiprofen_FDA.pdf?1539966813","parent_key":"BE0002793"}
{"ref-id":"F1933","title":"Nateglinide FD label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/933/original/Nateglinide_FDA.pdf?1539967335","parent_key":"BE0002793"}
{"ref-id":"F1617","title":"Riluzole FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/617/original/riluzole_fda_label.pdf?1537558079","parent_key":"BE0002433"}
{"ref-id":"F1934","title":"Zileuton FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/934/original/Zileuton_fda.pdf?1539967408","parent_key":"BE0002793"}
{"ref-id":"F1618","title":"Zileuton FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/618/original/Zileuton_FDA.pdf?1537558677","parent_key":"BE0002433"}
{"ref-id":"F1439","title":"Modafinil FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/439/original/Modafinil_FDA_label.pdf?1536356517","parent_key":"BE0003536"}
{"ref-id":"F1697","title":"Pharmacogenomics Table","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/697/original/Pharmacogenomic_Associations_Tables.pdf?1538151397","parent_key":"BE0002433"}
{"ref-id":"F1833","title":"Modafinil FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/833/original/Modafinil_FDA_label.pdf?1539620768","parent_key":"BE0002793"}
{"ref-id":"F1834","title":"Modafinil EMA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/834/original/modafinil-annex-iii-summary-product-characteristics-labeling-package-leaflet_en.pdf?1539621606","parent_key":"BE0002793"}
{"ref-id":"F1835","title":"Modafinil FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/835/original/Modafinil_FDA_label.pdf?1539621622","parent_key":"BE0002793"}
{"ref-id":"F1700","title":"Potential CYP2B6 Substrates, Inhibitors, Inudcers (https://ctep.cancer.gov/protocoldevelopment/docs/cyp2b6.doc)","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/700/original/cyp2b6.doc?1538154736","parent_key":"BE0003549"}
{"ref-id":"F1912","title":"Clopidogrel FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/912/original/Clopidogrel_FDA_label.pdf?1539882625","parent_key":"BE0002793"}
{"ref-id":"F1681","title":"Clopidogrel FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/681/original/Clopidogrel_fDA.pdf?1537991461","parent_key":"BE0002433"}
{"ref-id":"F1649","title":"Malathion, Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/649/original/mono112-07.pdf?1537830005","parent_key":"BE0002433"}
{"ref-id":"F1880","title":"Mefenamic Acid FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/880/original/Mefenamic_ACID_FDA.pdf?1539708891","parent_key":"BE0002793"}
{"ref-id":"F1811","title":"MONOGRAPH, Primidone","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/811/original/mono108-07.pdf?1539210539","parent_key":"BE0002793"}
{"ref-id":"F1462","title":"Primidine Prescribing Information, Canada","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/462/original/Primidione_Prescribing_Information__Canada.pdf?1536615314","parent_key":"BE0003536"}
{"ref-id":"F1512","title":"Primidone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/512/original/Prescribing_information__primidone.pdf?1537218769","parent_key":"BE0003536"}
{"ref-id":"F1897","title":"Atacand Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/897/original/ATACAND_-_Product-Monograph_001.pdf?1539799124","parent_key":"BE0002793"}
{"ref-id":"F1882","title":"Meloxicam FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/882/original/Meloxicam_FDA_label.pdf?1539709436","parent_key":"BE0002793"}
{"ref-id":"F2200","title":"Tadalafil FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/200/original/Tadalafil.pdf?1544547993","parent_key":"BE0002638"}
{"ref-id":"F1642","title":"Psychotropic Medications Metabolized by Cytochromes P450 (CYP) 1A2 Enzyme and Relevant Drug Interactions: Review of Articles","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/642/original/fulltext_ajpt-v4-id1085.pdf?1537817645","parent_key":"BE0002433"}
{"ref-id":"F1538","title":"Mifepristone FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/538/original/202107Orig1s000Lbl.pdf?1537305458","parent_key":"BE0002887"}
{"ref-id":"F1619","title":"Dacarbazine monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/619/original/Dacarbazine_monograph_1June2013_formatted.pdf?1537560136","parent_key":"BE0002433"}
{"ref-id":"F2201","title":"Vardenafil FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/201/original/Vardenafil.pdf?1544548213","parent_key":"BE0002638"}
{"ref-id":"F1620","title":"Zofran FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/620/original/Zofran_FDA_label.pdf?1537560512","parent_key":"BE0002433"}
{"ref-id":"F1586","title":"Cyclobenzaprine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/586/original/Cyclobenzaprine_FDA.pdf?1537396249","parent_key":"BE0002433"}
{"ref-id":"F1650","title":"Maprotiline Data Sheet","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/650/original/Maprotiline_New_Zealand_Data_sheet.pdf?1537889787","parent_key":"BE0002433"}
{"ref-id":"F1487","title":"CTEP.gov CYP2C19 document","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/487/original/cyp2c19.doc?1536956758","parent_key":"BE0003536"}
{"ref-id":"F1488","title":"EMA label, Telmisartan","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/488/original/EMA_label__telmisartan.pdf?1536956852","parent_key":"BE0003536"}
{"ref-id":"F2102","title":"DRUG-DRUG INTERACTIONS \u001a FROM KNOWLEDGE BASE TO CLINICAL IMPACT","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/102/original/Thesis_Marine_Andersson.pdf?1543427453","parent_key":"BE0003677"}
{"ref-id":"F1593","title":"Alosteron FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/593/original/FDA_label__Alosteron.pdf?1537460723","parent_key":"BE0002433"}
{"ref-id":"F1594","title":"CTEP CYP1A2 document, NIH","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/594/original/cyp1a2.pdf?1537461161","parent_key":"BE0002433"}
{"ref-id":"F4694","title":"Ezetimibe FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/694/original/Ezetimibe_FDA_label.pdf?1568145048","parent_key":"BE0002887"}
{"ref-id":"F1621","title":"Ramelteon FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/621/original/Ramelton_FDA_label.pdf?1537561082","parent_key":"BE0002433"}
{"ref-id":"F1622","title":"Fovatriptan FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/622/original/Fova.pdf?1537561737","parent_key":"BE0002433"}
{"ref-id":"F1925","title":"EMA Withdrawal Assessment Report for Direction (Ketoprofen Gel)","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/925/original/withdrawal-assessment-report-diractin_en.pdf?1539902762","parent_key":"BE0002793"}
{"ref-id":"F1623","title":"Cinacalcet FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/623/original/Cinacalcet_FDA_label.pdf?1537562294","parent_key":"BE0002433"}
{"ref-id":"F763","title":"Olux monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/763/original/1.pdf?1532387445","parent_key":"BE0002638"}
{"ref-id":"F1887","title":"Irbesartan FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/887/original/Irbesartan_FDA_label.pdf?1539710687","parent_key":"BE0002793"}
{"ref-id":"F1651","title":"CYP1A2 document, cancer.gov","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/651/original/cyp1a2.doc?1537894349","parent_key":"BE0002433"}
{"ref-id":"F1888","title":"FDA label, Ibuprofen","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/888/original/Ibuprofen_FDA_label.pdf?1539710857","parent_key":"BE0002793"}
{"ref-id":"F1930","title":"Connecticut's Official State Website: CYP Chart","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/930/original/CYPChartNov2013pdf.pdf?1539966142","parent_key":"BE0002793"}
{"ref-id":"F1827","title":"Fluvastatin FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/827/original/Fluvastatin_fda.pdf?1539373889","parent_key":"BE0002793"}
{"ref-id":"F1909","title":"Leflunomide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/909/original/Leflunomide_FDA_label.pdf?1539881381","parent_key":"BE0002793"}
{"ref-id":"F4652","title":"Health Canada Monograph - Rosuvastatin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/652/original/Health_Canada_Label_-_Rosuvastatin.PDF?1563989610","parent_key":"BE0002793"}
{"ref-id":"F1590","title":"Pimozide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/590/original/Pimozide_FDA.pdf?1537456704","parent_key":"BE0002433"}
{"ref-id":"F1861","title":"Capecitabine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/861/original/Capecitabine_fDA_label.pdf?1539638974","parent_key":"BE0002793"}
{"ref-id":"F2518","title":"Bicalutamide Labeling","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/518/original/Bicalutamide_Labeling.pdf?1546879119","parent_key":"BE0002638"}
{"ref-id":"F1936","title":"Carvedilol FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/936/original/Carvedilol_FDA_label.pdf?1539969426","parent_key":"BE0002793"}
{"ref-id":"F1643","title":"FDA label, Carvedilol","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/643/original/Carvedilol_FDA.pdf?1537818564","parent_key":"BE0002433"}
{"ref-id":"F1589","title":"Doxepin FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/589/original/Doxepin_FDA_label.pdf?1537397432","parent_key":"BE0002433"}
{"ref-id":"F1654","title":"Cilostazol EMA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/654/original/Cilostazol_EMA.pdf?1537902988","parent_key":"BE0002433"}
{"ref-id":"F1807","title":"Phenobarbital Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/807/original/Phenobarbital_Product_Monograph.pdf?1539207623","parent_key":"BE0002793"}
{"ref-id":"F1921","title":"Auspar Cyclizine","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/921/original/auspar-cyclizine-lactate-130115.pdf?1539892503","parent_key":"BE0002793"}
{"ref-id":"F2830","title":"Propafenone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/830/original/Propafenone_FDA_label.pdf?1547224520","parent_key":"BE0002363"}
{"ref-id":"F2830","title":"Propafenone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/830/original/Propafenone_FDA_label.pdf?1547224520","parent_key":"BE0002638"}
{"ref-id":"F1624","title":"Propafenone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/624/original/propafenone_fda_label.pdf?1537562720","parent_key":"BE0002433"}
{"ref-id":"F1647","title":"Domperidone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/647/original/Domperidone_FDA_label.pdf?1537825060","parent_key":"BE0002433"}
{"ref-id":"F1812","title":"Rifapentine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/812/original/RIfapentin.pdf?1539211801","parent_key":"BE0002793"}
{"ref-id":"F1813","title":"Induction of Drug Metabolism Enzymes and MDR1 Using a Novel Human Hepatocyte Cell Line","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/813/original/303.full.pdf?1539276370","parent_key":"BE0002793"}
{"ref-id":"F1433","title":"Rifaximin FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/433/original/Rifamixin_FDA.pdf?1536342184","parent_key":"BE0003536"}
{"ref-id":"F1580","title":"CYP1A2, CTEP document, NIH","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/580/original/cyp1a2.pdf?1537393556","parent_key":"BE0002433"}
{"ref-id":"F1581","title":"Cytochrome P450 Drug Interactions","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/581/original/cyp450_drug_interactions.pdf?1537393785","parent_key":"BE0002433"}
{"ref-id":"F2104","title":"DRUG-DRUG INTERACTIONS \u001a FROM KNOWLEDGE BASE TO CLINICAL IMPACT","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/104/original/Thesis_Marine_Andersson.pdf?1543428000","parent_key":"BE0003677"}
{"ref-id":"F2105","title":"The UDP-Glucuronosyltransferase 2B7 Isozyme Is Responsible for Gemfibrozil Glucuronidation in the Human Liver","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/105/original/a42abacc5d2af67bda8e706439f2fb7f1dad.pdf?1543428384","parent_key":"BE0003677"}
{"ref-id":"F1582","title":"Cytochrome P450 Interactions","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/582/original/cyp450_drug_interactions.pdf?1537393944","parent_key":"BE0003536"}
{"ref-id":"F1583","title":"Clomipramine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/583/original/FDA_Clomipramine.pdf?1537394120","parent_key":"BE0003536"}
{"ref-id":"F1585","title":"Clomipramine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/585/original/FDA_Clomipramine.pdf?1537395638","parent_key":"BE0002433"}
{"ref-id":"F2274","title":"FDA label, Ergonovine","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/274/original/Methylgonorvine_FDA_label.pdf?1544732464","parent_key":"BE0002638"}
{"ref-id":"F2265","title":"Dasatinib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/265/original/sprycel-epar-product-information_en.pdf?1544724679","parent_key":"BE0002638"}
{"ref-id":"F2364","title":"Vyvanse FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/364/original/Vyvanse_FDA_label.pdf?1545165585","parent_key":"BE0002363"}
{"ref-id":"F132","title":"EMA label, Lapatinib","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/132/original/EMA_label.pdf?1528400667","parent_key":"BE0002887"}
{"ref-id":"F770","title":"Verdeso monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/770/original/1.pdf?1532451429","parent_key":"BE0002638"}
{"ref-id":"F1800","title":"Formoterol FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/800/original/022007s004lbl.pdf?1539197397","parent_key":"BE0003336"}
{"ref-id":"F1890","title":"Formoterol FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/890/original/022007s004lbl-2.pdf?1539713510","parent_key":"BE0002793"}
{"ref-id":"F1625","title":"Rasagiline FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/625/original/Rasagiline_FDA_label.pdf?1537562987","parent_key":"BE0002433"}
{"ref-id":"F1803","title":"Ciprofloxacin FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/803/original/Ciprofloxacin_FDA.pdf?1539203883","parent_key":"BE0002433"}
{"ref-id":"F1577","title":"Acenocoumarol monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/577/original/Sintrom_en.pdf?1537391347","parent_key":"BE0002433"}
{"ref-id":"F1577","title":"Acenocoumarol monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/577/original/Sintrom_en.pdf?1537391347","parent_key":"BE0003536"}
{"ref-id":"F1686","title":"CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/686/original/Europe_CYP1A2.pdf?1538062575","parent_key":"BE0002433"}
{"ref-id":"F1524","title":"Phenobarbital Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/524/original/Phenobarbital_Product_Monograph.pdf?1537290461","parent_key":"BE0003536"}
{"ref-id":"F1735","title":"Quazepam FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/735/original/018708s018lbl.pdf?1538499862","parent_key":"BE0003549"}
{"ref-id":"F2271","title":"Everolimus FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/271/original/Everolimus_FDA_label.pdf?1544727368","parent_key":"BE0002638"}
{"ref-id":"F1515","title":"Kaletra, FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/515/original/FDA_label__Kaletra.pdf?1537221939","parent_key":"BE0003536"}
{"ref-id":"F1820","title":"Kaletra FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/820/original/FDA_label__Kaletra.pdf?1539298381","parent_key":"BE0002793"}
{"ref-id":"F1821","title":"Cytochrome P450 Enzymes and Transporters Induced by Anti-Human Immunodeficiency Virus Protease Inhibitors in Human Hepatocytes: Implications for Predicting Clinical Drug Interactions","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/821/original/303.full.pdf?1539359418","parent_key":"BE0002793"}
{"ref-id":"F1822","title":"Kaletra EPAR","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/822/original/kaletra-epar-product-information_en.pdf?1539360078","parent_key":"BE0002793"}
{"ref-id":"F1750","title":"Deferasirox FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/750/original/CYP1A2_Desferasirox.pdf?1538670223","parent_key":"BE0002433"}
{"ref-id":"F1752","title":"Exjade EMA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/752/original/Exjade_EMA.pdf?1538670841","parent_key":"BE0002433"}
{"ref-id":"F1641","title":"CYP1A2 cancer.gov document","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/641/original/cyp1a2.doc?1537816928","parent_key":"BE0002433"}
{"ref-id":"F1913","title":"Etoricoxib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/913/original/Etoricoxib_EMA.pdf?1539883309","parent_key":"BE0002793"}
{"ref-id":"F1926","title":"EMA Etoricoxib Assessment","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/926/original/arcoxia-article-6-12-referral-annex-i-ii-iii-iv_en.pdf?1539903083","parent_key":"BE0002793"}
{"ref-id":"F1705","title":"Etoricoxib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/705/original/Etoricoxib_FDA.pdf?1538174535","parent_key":"BE0002433"}
{"ref-id":"F1018","title":"CYP1A2 interactions","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/018/original/fulltext_ajpt-v4-id1085.pdf?1533748543","parent_key":"BE0002433"}
{"ref-id":"F1706","title":"Review of Toxicological Literature, NIH","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/706/original/resveratrol_508.pdf?1538174757","parent_key":"BE0002433"}
{"ref-id":"F1637","title":"CYP1A2 document, cancer.gov","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/637/original/cyp1a2.doc?1537810601","parent_key":"BE0002433"}
{"ref-id":"F1836","title":"CYP2C19 and CYP2C9: New aspects of pharmacogenetics and transcriptional regulation","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/836/original/b72f5f1e3db65e69d80fcff27b764fa6c84e.pdf?1539623371","parent_key":"BE0002793"}
{"ref-id":"F1910","title":"Nilotinib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/910/original/Nilotinib_FDA.pdf?1539881570","parent_key":"BE0002793"}
{"ref-id":"F973","title":"Priligy Data Sheet","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/973/original/Priligytab.pdf?1533315053","parent_key":"BE0002363"}
{"ref-id":"F1893","title":"Ximelagatran FDA Review","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/893/original/84280017D2DC4084B88D22698665EABA.pdf?1539715748","parent_key":"BE0002793"}
{"ref-id":"F1873","title":"Oritavancin FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/873/original/Oritavancin_FDA.pdf?1539706705","parent_key":"BE0002793"}
{"ref-id":"F1490","title":"Clevidipine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/490/original/Australian_Public_Assessment_Report-_Clevidipine.pdf?1536959804","parent_key":"BE0003536"}
{"ref-id":"F1676","title":"Lofexidine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/676/original/Lofexidine_FDA_label.pdf?1537980976","parent_key":"BE0002433"}
{"ref-id":"F1680","title":"Pirfenidone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/680/original/Pirfenidone_FDA_label.pdf?1537982169","parent_key":"BE0002433"}
{"ref-id":"F1496","title":"Dexlanzoprazole FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/496/original/Dexlanzoprazole_FDA.pdf?1536962749","parent_key":"BE0003536"}
{"ref-id":"F2309","title":"Camptosar FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/309/original/Camptosar_FDA_label.pdf?1544829108","parent_key":"BE0002638"}
{"ref-id":"F2113","title":"Telaprevir FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/113/original/Telaprevir_FDA_label.pdf?1543443951","parent_key":"BE0002638"}
{"ref-id":"F1860","title":"Brivaracetam FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/860/original/205836Orig1s000_205837Orig1s000_205838Orig1s000lbl.pdf?1539637180","parent_key":"BE0002793"}
{"ref-id":"F1754","title":"Abiraterone FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/754/original/Abiraterone_FDA_label.pdf?1538673769","parent_key":"BE0002433"}
{"ref-id":"F1443","title":"Zytiga product monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/443/original/Product_Monograph__Zytiga.pdf?1536358627","parent_key":"BE0003536"}
{"ref-id":"F1693","title":"DOVITINIB LACTATE Multikinase Inhibitor Antiongiogenic Agent Oncolytic","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/693/original/%28PDF%29_DOVITINIB_LACTATE_Multikinase_Inhibitor_Antiongiogenic_Agent_Oncolytic.pdf?1538147508","parent_key":"BE0002433"}
{"ref-id":"F1713","title":"Romidepsin FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/713/original/022393lbl.pdf?1538414579","parent_key":"BE0003549"}
{"ref-id":"F1885","title":"Tapentadol FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/885/original/022304s003lbl.pdf?1539710283","parent_key":"BE0002793"}
{"ref-id":"F1884","title":"Prasugrel FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/884/original/022307s002lbl.pdf?1539709914","parent_key":"BE0002793"}
{"ref-id":"F1656","title":"Eltrombopag FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/656/original/Eltrombopag_FDA_label.pdf?1537903211","parent_key":"BE0002433"}
{"ref-id":"F1634","title":"Asenapine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/634/original/Asenapine_FDA_label.pdf?1537809314","parent_key":"BE0002433"}
{"ref-id":"F1911","title":"Sitaxentan Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/911/original/Monograph__Sitaxentan.pdf?1539881907","parent_key":"BE0002793"}
{"ref-id":"F1927","title":"NPS Medicinewise Australian Prescriber: New Drugs","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/927/original/00804f708bf77b69e26e2f1ed7399ca081d894c713eb7752e303509af391.pdf?1539962927","parent_key":"BE0002793"}
{"ref-id":"F1483","title":"EMA Discussion Document, Sitaxentan","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/483/original/EMA_document_sitaxentan.pdf?1536870702","parent_key":"BE0003536"}
{"ref-id":"F2527","title":"Simeprevir FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/527/original/Simepravir_FDA_label.pdf?1546881223","parent_key":"BE0002638"}
{"ref-id":"F1724","title":"Forxiga Assessment report","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/724/original/forxiga-epar-public-assessment-report_en.pdf?1538434127","parent_key":"BE0002433"}
{"ref-id":"F1905","title":"Etravirine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/905/original/etravirine_fda.pdf?1539879709","parent_key":"BE0002793"}
{"ref-id":"F1510","title":"Selected Properties of Etravirine, HIVCLINIC.ca","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/510/original/NNRTI_etravirine.pdf?1537213291","parent_key":"BE0003536"}
{"ref-id":"F1657","title":"FDA Label, Pazopanib","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/657/original/Pazopanib_FDA.pdf?1537905265","parent_key":"BE0002433"}
{"ref-id":"F1695","title":"Midostaurin fDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/695/original/Midostaurin_FDA.pdf?1538148509","parent_key":"BE0002433"}
{"ref-id":"F1746","title":"Midostaurin FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/746/original/rydapt-epar-product-information_en.pdf?1538589714","parent_key":"BE0003549"}
{"ref-id":"F1507","title":"Midostaurin EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/507/original/WC500237581.pdf?1537209776","parent_key":"BE0002887"}
{"ref-id":"F1851","title":"Midostaurin FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/851/original/Midostaurin_FDA_label.pdf?1539632401","parent_key":"BE0002793"}
{"ref-id":"F1852","title":"Midostaurin EMA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/852/original/rydapt-epar-public-assessment-report_en.pdf?1539632437","parent_key":"BE0002793"}
{"ref-id":"F1495","title":"Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism and Excretion Studies of a BDDCS II Drug","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/495/original/Midostaurin.pdf?1536962250","parent_key":"BE0003536"}
{"ref-id":"F2196","title":"Apixaban FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/196/original/Apixaban_FDA_label.pdf?1544547159","parent_key":"BE0002638"}
{"ref-id":"F1658","title":"Apixaban FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/658/original/Apixaban_FDA_label.pdf?1537907015","parent_key":"BE0002433"}
{"ref-id":"F1659","title":"Axitinib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/659/original/Axitinib_FDA_label.pdf?1537907725","parent_key":"BE0002433"}
{"ref-id":"F1500","title":"Safinamide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/500/original/Safinamide_FDA_label.pdf?1536966040","parent_key":"BE0003536"}
{"ref-id":"F1504","title":"Safinamide, Pharmacology Review, FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/504/original/207145Orig1s000PharmR.pdf?1537198222","parent_key":"BE0003536"}
{"ref-id":"F1856","title":"Fosaprepitant FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/856/original/Fosaprepitant_FDA_label.pdf?1539634492","parent_key":"BE0002793"}
{"ref-id":"F1662","title":"Bendamustine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/662/original/Bendamustine_FDA.pdf?1537908965","parent_key":"BE0002433"}
{"ref-id":"F1915","title":"A Review on Drug Interactions in Oral Hypoglycemic Drugs by Mechanism of Cytochrome P450 Enzyme Inhibition","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/915/original/116434-271285-1-PB.pdf?1539884234","parent_key":"BE0002793"}
{"ref-id":"F1886","title":"Vismodegib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/886/original/203388lbl.pdf?1539710613","parent_key":"BE0002793"}
{"ref-id":"F1492","title":"Vismodegib","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/492/original/FDA_label__vismodegib.pdf?1536960870","parent_key":"BE0003536"}
{"ref-id":"F4667","title":"FDA Label - Pitavastatin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/667/original/FDA_Label_-_Pitavastatin.pdf?1564609735","parent_key":"BE0003679"}
{"ref-id":"F4667","title":"FDA Label - Pitavastatin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/667/original/FDA_Label_-_Pitavastatin.pdf?1564609735","parent_key":"BE0003677"}
{"ref-id":"F1883","title":"Pitavastatin FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/883/original/022363s000_Lbl.pdf?1539709679","parent_key":"BE0002793"}
{"ref-id":"F4667","title":"FDA Label - Pitavastatin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/667/original/FDA_Label_-_Pitavastatin.pdf?1564609735","parent_key":"BE0002887"}
{"ref-id":"F2182","title":"Rilpivirine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/182/original/Rilpivirine_FDA_label.pdf?1544472714","parent_key":"BE0002638"}
{"ref-id":"F1526","title":"Actual and Predicted Pharmacokinetic Interactions Between Anticonvulsants and Antiretrovirals","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/526/original/anticonvulsant-int.pdf?1537291056","parent_key":"BE0003536"}
{"ref-id":"F2328","title":"Ulipristal FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/328/original/FDA_label_ulipristal.pdf?1545079372","parent_key":"BE0002638"}
{"ref-id":"F2114","title":"Boceprevir FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/114/original/Boceprevir_FDA_label.pdf?1543446183","parent_key":"BE0002638"}
{"ref-id":"F1881","title":"Cabozantinib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/881/original/208692s000lbl.pdf?1539709355","parent_key":"BE0002793"}
{"ref-id":"F1702","title":"FDA label, Teriflunomide","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/702/original/Teriflunomide_FDA_label.pdf?1538155367","parent_key":"BE0002433"}
{"ref-id":"F1540","title":"Vemurafenib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/540/original/202429s012lbl-3.pdf?1537307489","parent_key":"BE0002887"}
{"ref-id":"F1782","title":"Vemurafenib EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/782/original/anx_133338_en.pdf?1538779315","parent_key":"BE0003549"}
{"ref-id":"F1682","title":"Perampanel FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/682/original/Perampanel_FDA.pdf?1537995594","parent_key":"BE0002433"}
{"ref-id":"F400","title":"Regorafenib","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/400/original/regorafenib.pdf?1530737152","parent_key":"BE0002638"}
{"ref-id":"F400","title":"Regorafenib","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/400/original/regorafenib.pdf?1530737152","parent_key":"BE0003538"}
{"ref-id":"F1732","title":"Regorafenib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/732/original/203085lbl.pdf?1538498947","parent_key":"BE0003549"}
{"ref-id":"F1837","title":"Enzalutamide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/837/original/Enzalutamide_FDA_label.pdf?1539623762","parent_key":"BE0002793"}
{"ref-id":"F1838","title":"Xtandi Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/838/original/Xtandi_PM_EN.pdf?1539624088","parent_key":"BE0002793"}
{"ref-id":"F1520","title":"Ezalutamide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/520/original/Ezalutamide_FDA_label.pdf?1537286678","parent_key":"BE0003536"}
{"ref-id":"F1733","title":"Enzalutamide FDA Review","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/733/original/203415Orig1s000ClinPharmR.pdf?1538499376","parent_key":"BE0003549"}
{"ref-id":"F1513","title":"Xtandi monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/513/original/1.pdf?1537219227","parent_key":"BE0002362"}
{"ref-id":"F4316","title":"FDA label, Invokana","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/316/original/Invokana_FDA_label.pdf?1554933115","parent_key":"BE0003538"}
{"ref-id":"F4313","title":"Invokana, Canadian monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/313/original/Invokana__Canadian_monograph.pdf?1554913610","parent_key":"BE0003538"}
{"ref-id":"F4316","title":"FDA label, Invokana","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/316/original/Invokana_FDA_label.pdf?1554933115","parent_key":"BE0003681"}
{"ref-id":"F4313","title":"Invokana, Canadian monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/313/original/Invokana__Canadian_monograph.pdf?1554913610","parent_key":"BE0003681"}
{"ref-id":"F4316","title":"FDA label, Invokana","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/316/original/Invokana_FDA_label.pdf?1554933115","parent_key":"BE0002638"}
{"ref-id":"F1660","title":"Pomalidomide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/660/original/FDA_label__pomalidomide.pdf?1537908060","parent_key":"BE0002433"}
{"ref-id":"F527","title":"EMA Label: Tafinlar (dabrafenib mesilate) Summary of Product Characteristics","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/527/original/WC500149671.pdf?1531326533","parent_key":"BE0002793"}
{"ref-id":"F1441","title":"Luliconazole FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/441/original/Luliconazole_FDA_label.pdf?1536357038","parent_key":"BE0003536"}
{"ref-id":"F1801","title":"Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/801/original/Determination_of_the_inhibitory_potential_of_6_fluoroquinolones_on_CYP1A2_and_CYP2C9_in_human_liver_.pdf?1539203695","parent_key":"BE0002433"}
{"ref-id":"F1802","title":"FDA label, ciprofloxacin","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/802/original/Ciprofloxacin_FDA.pdf?1539203799","parent_key":"BE0002433"}
{"ref-id":"F1877","title":"Netupitant FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/877/original/205718s000lbl.pdf?1539708002","parent_key":"BE0002793"}
{"ref-id":"F1493","title":"Australian Public Assessment Report: Naloxegol","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/493/original/auspar-naloxegol-oxalate-160601.pdf?1536961409","parent_key":"BE0003536"}
{"ref-id":"F1491","title":"Lumacraftor Australian Prescribing Information","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/491/original/auspar-lumacaftor-ivacaftor-160908-pi.pdf?1536959860","parent_key":"BE0002887"}
{"ref-id":"F1744","title":"Idelalisib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/744/original/205858lbl.pdf?1538589070","parent_key":"BE0003549"}
{"ref-id":"F1857","title":"Cannabidiol World Health Organization Review","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/857/original/5.2_CBD.pdf?1539635882","parent_key":"BE0002793"}
{"ref-id":"F1677","title":"Tasimelteon FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/677/original/Tasimelteon_FDA_label.pdf?1537981173","parent_key":"BE0002433"}
{"ref-id":"F2974","title":"Linparza (olaparib) drug monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/974/original/olaparib_%28capsule%29.pdf?1547681847","parent_key":"BE0002638"}
{"ref-id":"F1742","title":"Olaparib Health Canada Product Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/742/original/00045123.PDF?1538588569","parent_key":"BE0003549"}
{"ref-id":"F1743","title":"Olaparib EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/743/original/lynparza-epar-product-information_en.pdf?1538588669","parent_key":"BE0003549"}
{"ref-id":"F1874","title":"Olodaterol FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/874/original/203108s006lbl.pdf?1539707193","parent_key":"BE0002793"}
{"ref-id":"F773","title":"Nerisone monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/773/original/1.pdf?1532452451","parent_key":"BE0002638"}
{"ref-id":"F2266","title":"FDA label: Stribild","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/266/original/Elvitegravir_FDA.pdf?1544725244","parent_key":"BE0002638"}
{"ref-id":"F1388","title":"EMA label, stiripentol","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/388/original/Stiripentol_and_EMA_label.pdf?1536161386","parent_key":"BE0003536"}
{"ref-id":"F1388","title":"EMA label, stiripentol","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/388/original/Stiripentol_and_EMA_label.pdf?1536161386","parent_key":"BE0002433"}
{"ref-id":"F1444","title":"Zuacta Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/444/original/zuacta_monograph.pdf?1536359200","parent_key":"BE0003536"}
{"ref-id":"F1868","title":"Zuacta Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/868/original/Zuacta_Monograph.pdf?1539642694","parent_key":"BE0002793"}
{"ref-id":"F1639","title":"Sanofi Canada: ZUACTA (zucapsaicin cream, 0.075% w/w) Prescribing Information","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/639/original/zuacta.pdf?1537810886","parent_key":"BE0003533"}
{"ref-id":"F2289","title":"WHO Critical Review: Etizolam","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/289/original/WHO_Crit.pdf?1544745221","parent_key":"BE0003536"}
{"ref-id":"F1675","title":"Zotepine monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/675/original/zotepine_monograph.pdf?1537980859","parent_key":"BE0002433"}
{"ref-id":"F1830","title":"Artesunate and Amiodiquine FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/830/original/Artesunate_and_Amodiquine.pdf?1539617705","parent_key":"BE0003336"}
{"ref-id":"F1745","title":"Lumacaftor/Ivacaftor FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/745/original/uspi_lumacaftor_ivacaftor-2.pdf?1538589421","parent_key":"BE0003549"}
{"ref-id":"F1506","title":"Lumacaftor/Ivacaftor FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/506/original/uspi_lumacaftor_ivacaftor.pdf?1537209167","parent_key":"BE0002887"}
{"ref-id":"F1839","title":"Lumacaftor FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/839/original/Lumacaftor_FDA_label.pdf?1539624333","parent_key":"BE0002793"}
{"ref-id":"F1521","title":"Lumacaftor FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/521/original/Lumacaftor_FDA_label.pdf?1537288298","parent_key":"BE0003536"}
{"ref-id":"F1685","title":"Propacetamol Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/685/original/PROPACETAMOL_PRESCRIBING_INFO.pdf?1538001584","parent_key":"BE0002433"}
{"ref-id":"F1701","title":"Osimertinib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/701/original/Osimertinib_FDA.pdf?1538154826","parent_key":"BE0002433"}
{"ref-id":"F1608","title":"List of Drugs Interacting with CYP3A4 - The Cancer Therapy Evaluation Program (CTEP)","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/608/original/List_of_Drugs_Interacting_with_CYP3A4_-_The_Cancer_Therapy_Evaluation_Program_%28CTEP%29.pdf?1537544013","parent_key":"BE0002638"}
{"ref-id":"F1661","title":"Ixazomib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/661/original/Ixazomib.pdf?1537908566","parent_key":"BE0002433"}
{"ref-id":"F1712","title":"Ixazomib EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/712/original/ninlaro-epar-product-information_en.pdf?1538414359","parent_key":"BE0003549"}
{"ref-id":"F1474","title":"EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/474/original/WC500217620.pdf?1536793163","parent_key":"BE0002887"}
{"ref-id":"F1865","title":"Ixazomib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/865/original/208462lbl.pdf?1539642476","parent_key":"BE0002793"}
{"ref-id":"F1723","title":"A Review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L)","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/723/original/peppermint_oil.pdf?1538429254","parent_key":"BE0002433"}
{"ref-id":"F1475","title":"Selexipag FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/475/original/207947s001lbl.pdf?1536793316","parent_key":"BE0002887"}
{"ref-id":"F804","title":"Melegestrol acetate, Australia","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/804/original/1.pdf?1532544308","parent_key":"BE0002638"}
{"ref-id":"F1862","title":"Lesinurad FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/862/original/207988lbl.pdf?1539641643","parent_key":"BE0002793"}
{"ref-id":"F2123","title":"Venclexta FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/123/original/Venclexta_FDA_label.pdf?1543868185","parent_key":"BE0002638"}
{"ref-id":"F1714","title":"Sofosbuvir and Velpatasvir FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/714/original/208341s007lbl.pdf?1538414793","parent_key":"BE0003549"}
{"ref-id":"F1715","title":"Sofosbuvir and Velpatasvir EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/715/original/epclusa-epar-product-information_en.pdf?1538414830","parent_key":"BE0003549"}
{"ref-id":"F1477","title":"VOSEVI (sofosbuvir, velpatasvir, and voxilaprevir) FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/477/original/vosevi_pi.pdf?1536861147","parent_key":"BE0002887"}
{"ref-id":"F1859","title":"Rupatadine Canadian Prescribing Information","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/859/original/RUPALL-monograph-EN.pdf?1539636355","parent_key":"BE0002793"}
{"ref-id":"F1505","title":"Opicapone EMA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/505/original/Opicapone_EMA.pdf?1537199944","parent_key":"BE0003536"}
{"ref-id":"F1497","title":"Opicapone EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/497/original/anx_135047_en.pdf?1536965128","parent_key":"BE0002887"}
{"ref-id":"F1854","title":"Isavuconazole FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/854/original/Isavuconazole_FDA_label.pdf?1539633382","parent_key":"BE0002793"}
{"ref-id":"F1696","title":"Pitilosant FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/696/original/Pitilosant_FDA.pdf?1538148649","parent_key":"BE0002433"}
{"ref-id":"F1748","title":"Pitolisant EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/748/original/anx_133706_en.pdf?1538592778","parent_key":"BE0003549"}
{"ref-id":"F114","title":"European Medicines Agency (EMA): Assessment report on Curcuma xanthorrhiza Roxb. (C. xanthorrhiza D. Dietrich)., rhizoma","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/114/original/WC500144564.pdf?1527261710","parent_key":"BE0002793"}
{"ref-id":"F114","title":"European Medicines Agency (EMA): Assessment report on Curcuma xanthorrhiza Roxb. (C. xanthorrhiza D. Dietrich)., rhizoma","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/114/original/WC500144564.pdf?1527261710","parent_key":"BE0002638"}
{"ref-id":"F114","title":"European Medicines Agency (EMA): Assessment report on Curcuma xanthorrhiza Roxb. (C. xanthorrhiza D. Dietrich)., rhizoma","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/114/original/WC500144564.pdf?1527261710","parent_key":"BE0003549"}
{"ref-id":"F114","title":"European Medicines Agency (EMA): Assessment report on Curcuma xanthorrhiza Roxb. (C. xanthorrhiza D. Dietrich)., rhizoma","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/114/original/WC500144564.pdf?1527261710","parent_key":"BE0002433"}
{"ref-id":"F114","title":"European Medicines Agency (EMA): Assessment report on Curcuma xanthorrhiza Roxb. (C. xanthorrhiza D. Dietrich)., rhizoma","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/114/original/WC500144564.pdf?1527261710","parent_key":"BE0002363"}
{"ref-id":"F379","title":"Encorafenib review","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/379/original/Encorafenib_Review.pdf?1530720666","parent_key":"BE0002638"}
{"ref-id":"F379","title":"Encorafenib review","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/379/original/Encorafenib_Review.pdf?1530720666","parent_key":"BE0003536"}
{"ref-id":"F379","title":"Encorafenib review","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/379/original/Encorafenib_Review.pdf?1530720666","parent_key":"BE0002363"}
{"ref-id":"F3814","title":"Spravato FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/814/original/Spravato_FDA_label.pdf?1551896525","parent_key":"BE0003549"}
{"ref-id":"F3817","title":"Spravato FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/817/original/Spravato_FDA_label.pdf?1551896554","parent_key":"BE0002638"}
{"ref-id":"F3820","title":"Spravato FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/820/original/Spravato_FDA_label.pdf?1551897479","parent_key":"BE0003536"}
{"ref-id":"F3823","title":"Spravato FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/823/original/Spravato_FDA_label.pdf?1551897504","parent_key":"BE0002793"}
{"ref-id":"F1481","title":"Apalutamide FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/481/original/210951s000lbl-2.pdf?1536864092","parent_key":"BE0002887"}
{"ref-id":"F1431","title":"Apalutamide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/431/original/Apalutamide_FDA.pdf?1536340059","parent_key":"BE0003536"}
{"ref-id":"F1432","title":"Erleada (apalutamide) monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/432/original/Erleada_FDA_label.pdf?1536340075","parent_key":"BE0003536"}
{"ref-id":"F1819","title":"Apalutamide FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/819/original/Apalutamide_FDA.pdf?1539297404","parent_key":"BE0002793"}
{"ref-id":"F1823","title":"Erleada monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/823/original/ERLEADA-pi.pdf?1539361821","parent_key":"BE0002793"}
{"ref-id":"F367","title":"EMA assessment report","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/367/original/EMA_withdrawal_letter.pdf?1530652842","parent_key":"BE0002433"}
{"ref-id":"F1725","title":"FDA label, Binimetinib","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/725/original/FDA_label_bini.pdf?1538434262","parent_key":"BE0002433"}
{"ref-id":"F1824","title":"Avatrombopag FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/824/original/Avatrombopag_FDA_label.pdf?1539362386","parent_key":"BE0002793"}
{"ref-id":"F1665","title":"Voxilaprevir FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/665/original/Voxilaprevir_FDA.pdf?1537911858","parent_key":"BE0002433"}
{"ref-id":"F1666","title":"Management of Unique Populations with HCV Infection","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/666/original/a2c6786846e0cb95193716302d2cc4b6b757.pdf?1537912099","parent_key":"BE0002433"}
{"ref-id":"F1478","title":"VOSEVI ( (sofosbuvir, velpatasvir, and voxilaprevir) FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/478/original/vosevi_pi.pdf?1536861615","parent_key":"BE0002887"}
{"ref-id":"F1522","title":"Letermovir FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/522/original/LETERMOVIR_FDA_LABEL.pdf?1537288530","parent_key":"BE0003536"}
{"ref-id":"F1523","title":"Letermovir FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/523/original/Prevymis__EMA_label.pdf?1537288966","parent_key":"BE0003536"}
{"ref-id":"F1853","title":"Letermovir FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/853/original/letermovir_fda.pdf?1539632684","parent_key":"BE0002793"}
{"ref-id":"F1747","title":"Letermovir EMA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/747/original/prevymis-epar-public-assessment-report_en.pdf?1538591893","parent_key":"BE0003549"}
{"ref-id":"F4402","title":"Erdafitinib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/402/original/212018s000lbl.pdf?1555368103","parent_key":"BE0002793"}
{"ref-id":"F4402","title":"Erdafitinib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/402/original/212018s000lbl.pdf?1555368103","parent_key":"BE0002638"}
{"ref-id":"F1664","title":"Deutetrabenazine FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/664/original/Deutetrabenazine_FDA.pdf?1537911236","parent_key":"BE0002433"}
{"ref-id":"F3571","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/571/original/Egaten_FDA_label.pdf?1550684579","parent_key":"BE0002433"}
{"ref-id":"F3568","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/568/original/Egaten_FDA_label.pdf?1550684563","parent_key":"BE0002793"}
{"ref-id":"F3577","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/577/original/Egaten_FDA_label.pdf?1550685318","parent_key":"BE0002638"}
{"ref-id":"F3580","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/580/original/Egaten_FDA_label.pdf?1550685347","parent_key":"BE0003543"}
{"ref-id":"F3583","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/583/original/Egaten_FDA_label.pdf?1550685388","parent_key":"BE0001111"}
{"ref-id":"F3586","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/586/original/Egaten_FDA_label.pdf?1550685417","parent_key":"BE0003536"}
{"ref-id":"F3589","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/589/original/Egaten_FDA_label.pdf?1550685445","parent_key":"BE0002363"}
{"ref-id":"F3592","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/592/original/Egaten_FDA_label.pdf?1550686032","parent_key":"BE0003336"}
{"ref-id":"F3595","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/595/original/Egaten_FDA_label.pdf?1550686050","parent_key":"BE0002887"}
{"ref-id":"F3598","title":"Egaten FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/598/original/Egaten_FDA_label.pdf?1550686065","parent_key":"BE0003549"}
{"ref-id":"F1473","title":"Eravacycline FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/473/original/Eravacycline_FDA_label.pdf?1536790055","parent_key":"BE0002638"}
{"ref-id":"F1663","title":"Rupacarib","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/663/original/Rupacarib_FDA.pdf?1537909073","parent_key":"BE0002433"}
{"ref-id":"F4196","title":"Siponimod FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/196/original/Siponimod_FDA_label.pdf?1554153879","parent_key":"BE0002638"}
{"ref-id":"F4196","title":"Siponimod FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/196/original/Siponimod_FDA_label.pdf?1554153879","parent_key":"BE0002793"}
{"ref-id":"F767","title":"Eumovate cream monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/767/original/1.pdf?1532446750","parent_key":"BE0002638"}
{"ref-id":"F1454","title":"Acid peptic diseases: pharmacological approach to treatment","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/454/original/Acid_peptic_diseases_Pharmacological_approach_to_t.pdf?1536602544","parent_key":"BE0003536"}
{"ref-id":"F1668","title":"Enasidenib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/668/original/Enadisenib_FDA_label.pdf?1537912686","parent_key":"BE0002433"}
{"ref-id":"F1716","title":"Enasidenib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/716/original/209606s000lbl-2.pdf?1538416178","parent_key":"BE0003549"}
{"ref-id":"F1479","title":"Enasidenib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/479/original/209606s000lbl.pdf?1536861874","parent_key":"BE0002887"}
{"ref-id":"F1858","title":"Enasidenib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/858/original/209606s000lbl-3.pdf?1539636102","parent_key":"BE0002793"}
{"ref-id":"F1498","title":"Enasidenib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/498/original/Enasidenib_FDA.pdf?1536965261","parent_key":"BE0003536"}
{"ref-id":"F1499","title":"Eurartesim EMA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/499/original/piperaquine.pdf?1536965668","parent_key":"BE0003536"}
{"ref-id":"F1670","title":"CYP1A2 CTEP cancer.gov","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/670/original/cyp1a2.doc?1537975412","parent_key":"BE0002433"}
{"ref-id":"F1669","title":"CYP1A2 document, cancer.gov","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/669/original/cyp1a2.doc?1537914124","parent_key":"BE0002433"}
{"ref-id":"F1671","title":"CYP1A2 CTEP cancer.gov","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/671/original/cyp1a2.doc?1537975784","parent_key":"BE0002433"}
{"ref-id":"F1673","title":"Cancer.gov CTEP CYP1A2 document","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/673/original/cyp1a2.doc?1537979489","parent_key":"BE0002433"}
{"ref-id":"F1674","title":"CYP1A2 cancer.gov CTEP","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/674/original/cyp1a2.doc?1537980001","parent_key":"BE0002433"}
{"ref-id":"F2079","title":"Baloxavir Marboxil FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/079/original/Baloxavir_Marboxil_FDA_label.pdf?1543256133","parent_key":"BE0003677"}
{"ref-id":"F2079","title":"Baloxavir Marboxil FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/079/original/Baloxavir_Marboxil_FDA_label.pdf?1543256133","parent_key":"BE0002638"}
{"ref-id":"F1840","title":"Nabilone FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/840/original/018677s011lbl-2.pdf?1539624376","parent_key":"BE0002793"}
{"ref-id":"F1842","title":"Nabiximols AUSPAR Profile","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/842/original/auspar-nabiximols-130927-pi.pdf?1539625514","parent_key":"BE0002793"}
{"ref-id":"F1683","title":"Pilocarpine pharmacology review, FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/683/original/200890_pilocarpine_clinpharm_PREA.pdf?1537998135","parent_key":"BE0002433"}
{"ref-id":"F1749","title":"Ivosidenib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/749/original/211192s000lbl-2.pdf?1538592989","parent_key":"BE0003549"}
{"ref-id":"F1855","title":"Ivosidenib FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/855/original/Ivosidenib_FDA_label.pdf?1539634060","parent_key":"BE0002793"}
{"ref-id":"F1508","title":"Ivosidenib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/508/original/211192s000lbl.pdf?1537211522","parent_key":"BE0002887"}